INTRODUCTION Adiponectin is adipocytokin with anti-inflammatory and anti-atherogenic effects. However, studies examining the relationship between adiponectin and cardiovascular diseases have shown inconsistent results. AIMS The aim of this study was to evaluate the plasma levels of adiponectin in clinically asymptomatic subjects with various dyslipidemic phenotypes. The associations between a...

Visceral obesity is the most prevalent manifestation of metabolic syndrome and is a marker of dysfunctional adipose tissue and ectopic fat infiltration [1,2]. The initiation of derangement of metabolic health strongly correlates with insulin resistance and systemic inflammation derived from inflamed visceral adipose tissue [3]. Not just having a large amount of fat in body, but also the depot-s...

Background: Prevention strategies post-stroke should target risk factor reduction which includes consideration of weight, diet and lipoprotein profiles. Limited data informs the optimal adiposity measurement post-stroke to target those at highest recurrent risk. This study aims to identify adiposity measurement/s post-stroke that best predict cardiovascular and co-morbid risk. Subjects and Meth...

BackgroundThe combination of abdominal obesity and elevated triglycerides (TG), i.e. hypertriglyceridemic waist, is a known risk factor for coronary heart disease. Abdominal adiposity also to increase the atrial fibrillation (AF). Yet, lipid paradox has been described, where lower levels low-density lipoproteins (LDL) TG were associated with higher AF. We evaluated role profile on incidence pos...

INTRODUCTION There is an increasing interest in the association between erectile dysfunction (ED) and cardiovascular risk factor. Epicardial adipose tissue (EAT) is associated with insulin resistance, increased cardiometabolic risk, and coronary artery disease. Our aim was to investigate relationships between epicardial fat thickness (EFT) as a cardiometabolic risk factor and erectile dysfuncti...